
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>103-182</title>
    </head>

    <body>
        <h1>
        <a href="./103_181.html" rel="external" title="prev">≪</a>
        103-182
        <a href="./103_183.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p><img alt="" class="alignnone size-full wp-image-3191" height="73.5" loading="lazy" sizes="(max-width: 510px) 100vw, 510px" src="data:;base64,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" width="357.0"/></p>
<ol><li>ドネペジル塩酸塩の増量</li><li>リバスチグミンの併用</li><li>ガランタミン臭化水素酸塩の併用</li><li>メマンチン塩酸塩の併用</li><li>メチルフェニデート塩酸塩の併用</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            1, 4
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <p><span style="font-weight: 400;">選択肢 1 は、正しい記述です。<br/></span><span style="font-weight: 400;">ドネペジルは、まず副作用回避の目的で</span><span style="font-weight: 400;">3mg から投与しますが、その後 5mg に増加し、</span><span style="font-weight: 400;">さらに 10mg まで増量できます。</span><span style="font-weight: 400;">最近悪化している傾向が見られるため</span><span style="font-weight: 400;">妥当な方針といえます。</span></p>
<p><span style="font-weight: 400;">選択肢 2,3 ですが<br/></span><span style="font-weight: 400;">リバスチグミンは、</span><span style="font-weight: 400;">商品名イクセロンパッチのことです。</span><span style="font-weight: 400;">ガランタミンは、レミニールのことです。</span><span style="font-weight: 400;">共に、ドネペジルと同じ機序である</span><span style="font-weight: 400;">AchE 阻害剤です。</span><span style="font-weight: 400;">AchE阻害剤は、併用では用いられません。</span><span style="font-weight: 400;">よって、選択肢 2,3 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 4 は、正しい記述です。<br/></span><span style="font-weight: 400;">メマンチン（メマリー）は、</span><span style="font-weight: 400;">NMDA 受容体遮断薬です。</span><span style="font-weight: 400;">中等度から高度</span><span style="font-weight: 400;">アルツハイマー型認知症の</span><span style="font-weight: 400;">適用をもつ薬剤です。</span><span style="font-weight: 400;">ドネペジルと併用が可能です。</span></p>
<p><span style="font-weight: 400;">選択肢 5 ですが<br/></span><span style="font-weight: 400;">メチルフェニデート（リタリン、コンサータ）は、</span><span style="font-weight: 400;">ナルコレプシー（病的眠気）や</span><span style="font-weight: 400;">注意欠陥／多動性障害（ADHD）</span><span style="font-weight: 400;">に用いられる薬です。</span></p>
<p><span style="font-weight: 400;">以上より、正解は 1,4 です。<br/></span><span style="font-weight: 400;">類題　</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    